Norge -
norsk -
Statens legemiddelverk
metformin zentiva 1000 mg
zentiva k.s. - metforminhydroklorid - tablett, filmdrasjert - 1000 mg
Norge -
norsk -
Statens legemiddelverk
metformin zentiva 500 mg
zentiva k.s. - metforminhydroklorid - tablett, filmdrasjert - 500 mg
Norge -
norsk -
Statens legemiddelverk
metformin zentiva 850 mg
zentiva k.s. - metforminhydroklorid - tablett, filmdrasjert - 850 mg
Norge -
norsk -
Statens legemiddelverk
mibg [123i] 74 mbq/ ml
curium netherlands b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml
Norge -
norsk -
Statens legemiddelverk
adreview-iobenguane (123i) injection 74 mbq/ ml
ge healthcare b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml
Den europeiske union -
norsk -
EMA (European Medicines Agency)
pylclari
curium pet france - piflufolastat (18f) - prostata neoplasmer - diagnostiske radiopharmaceuticals - dette legemidlet er kun til diagnostisk bruk. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).